Natixis’s MiMedx Group MDXG Stock Holding History

Natixis’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-14,845	Closed	-$176K	–	1037
2017 Q3	$176K	Buy	+14,845	New	+$220K	﹤0.01%	1148
2017 Q1	–	Sell	-10,982	Closed	-$97K	–	999
2016 Q4	$97K	Buy	+10,982	New	+$98.7K	﹤0.01%	851

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Natixis's MDXG Position: Q4 2017 in Review

Natixis sold out of MiMedx Group (MDXG) in Q4 2017, closing a stake of 14,845 shares — an estimated $176K sold.

Natixis first reported a position in MDXG in Q4 2016 and held it in 2 quarters. The position peaked at $176K in Q3 2017. 236 funds tracked by Wall St. Rank hold MDXG as of Q4 2017.

Natixis reported no remaining MiMedx Group position as of Q4 2017 after selling out during the quarter.
Natixis sold 14,845 MiMedx Group shares in Q4 2017, an estimated $176K.
Natixis first reported a position in MiMedx Group in Q4 2016 and held it in 2 quarters.
Natixis's MiMedx Group position peaked at $176K in Q3 2017.
236 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2017.

Based on Natixis's 13F filing for Q4 2017, filed 14 Feb 2018.